Vensana Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
12
- Portfolio
-
10
- Exits
-
4
Vensana Capital General Information
Description
Founded in 2019, Vensana Capital is a venture capital and growth equity investment firm based in Minneapolis, Minnesota. The firm seeks to invest in companies operating in the medical devices, diagnostics and data science, drug delivery, digital health, life science tools and tech-enabled services sectors.
Contact Information
Website
www.vensanacap.com
Year Founded
2019
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 3601 West 76th Street
- Suite 20
- Minneapolis, MN 55435
- United States
+1 (612) 000-0000
Vensana Capital Investments (12)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ChromaCode | 03-Mar-2022 | Later Stage VC | 0000 | Diagnostic Equipment | Generating Revenue | |
| 000000 (00000 0000 | 22-Dec-2021 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Startup | 000000 00000 00 |
| 0000000 | 21-Jun-2021 | 00000 00000 | 0000 | Decision/Risk Analysis | Generating Revenue | 000000 00000 00 |
| 000000 00000000000 | 23-Apr-2021 | 00000 00000 | 0000 | Biotechnology | Product Development | 000000 00000 00 |
| 00000000 000000 00 | 10-Feb-2021 | 00000 00000 | 00000 | Discovery Tools (Healthcare) | Generating Revenue | 000000 00000 00 |
| 00000000 000000000 | 11-Jan-2021 | 00000 00000 | 000.00 | Other Devices and Supplies | Startup | 0000 0000000 |
| 000000000 0000000 | 05-Nov-2020 | 00000 00000 | 0000 | Therapeutic Devices | Clinical Trials - Phase 2 | 0000 0000000 |
| 000000000 00000000 | 29-Oct-2020 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 000000 00000 00 |
| CVRx | 07-Jul-2020 | Later Stage VC | 0000 | Therapeutic Devices | Generating Revenue/Not Profitable | 0000 0000000 |
| Intact Vascular | 05-May-2020 | Later Stage VC | 000.00 | Other Devices and Supplies | Generating Revenue | 000000 00000 00 |
Vensana Capital Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Personal Genome Diagnostics | 21-Feb-2022 | Merger/Acquisition | 00000 |
| 0000 | 30-Jun-2021 | 000 | 00000 |
| 000000 00000000 | 04-Sep-2020 | 000000000000000000 | 00000 |
Vensana Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Vensana Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Vensana Capital Team (34)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Justin Klein MD | Co-Founder & Managing Partner | 00 | 0 | 0 | Minneapolis, MN |
| Cynthia Yee | Principal | 0 | Minneapolis, MN | ||
| Greg Banker MD | Vice President | Minneapolis, MN | |||
| Leslie Trigg | Advisor | Minneapolis, MN | |||
| Nadim Yared | Advisor | Minneapolis, MN |
Vensana Capital Co-Investors (36)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| New Enterprise Associates | 6 | 0 | 0 |
|
|
| Gilde Healthcare Partners | 0 | 0 | 0 |
|
|
| PFM Health Sciences | 0 | 0 | 0 |
|
|
| Quaker Partners | 0 | 0 | 0 |
|
|
| Morgenthaler Ventures | 0 | 0 |
|
|